Evidence map›Paper›PMID 38496708›Full record

Review3 Biotech2024

A review on pharmacological studies of natural flavanone: pinobanksin.

Brindha Elangovan

Open access · greenAbstract readReview
In one paragraph

Review in 3 Biotech, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Brindha ElangovanSt. Justin Arts and Science College for Women, NH-226, Masathiyar Nagar, Sholavaram, Sivaganga, Tamil Nadu 630 557 India.ORCID 0000-0002-5383-4207
ASA College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herbal medicinal drugs, or phytotherapy, have historically played a pivotal role in treating human ailments. In the contemporary medical landscape, there is a burgeoning interest in natural products owing to their diverse and health-beneficial components. Among these, bioactive phytochemicals represent a dynamic area of global research. This study focuses on pinobanksin, a potential polyphenolic component identified through meticulous scientific research and purified using advanced chromatographic techniques from various sources, including plants, propolis, and honey. Pinobanksin has emerged as a compelling subject of investigation, exhibiting a spectrum of pharmacological effects. Scientific studies have unveiled its prowess as an anti-oxidant, anti-bacterial, anti-inflammatory, anti-parasitic, anti-mutagenic, anti-proliferative, and anti-angiogenic agent. This literature review systematically synthesizes the existing body of research on pinobanksin, providing a comprehensive overview of its diverse pharmacological activities. In light of its multifaceted pharmacological profile, pinobanksin stands out as a promising scaffold for future drug discovery endeavors. This review not only consolidates the current understanding of pinobanksin's bioactivities but also underscores its potential as a valuable candidate for advancing therapeutic interventions.

Indexed as

FlavonoidPharmacological propertiesPhytochemicalPinobanksin

Identifiers

PMID38496708
PMCPMC10937894
OpenAlexW4392744930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.